Castle Biosciences Inc
CSTL· Nasdaq
CSTLCastle Biosciences Inc
Filed Mar 11, 2021 · 10-K · 70 days after period end · 0001447362-21-000047
| Metric | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|
| Revenue | $17.30M | $17.64M | $11.44M |
| Net Income | -$4.89M | $2.06M | $3.87M |
| EPS Diluted | -$0.23 | $0.11 | $0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Castle Biosciences Inc · CIK 1447362 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 11, 2021 · 70 d after period end
